- Home
- CTMX vs PHUN Comparison
CTMX vs PHUN Comparison
Compare CTMX & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- PHUN
- Stock Information
- Founded
- CTMX 2008
- PHUN 2009
- Country
- CTMX United States
- PHUN United States
- Employees
- CTMX N/A
- PHUN N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- PHUN EDP Services
- Sector
- CTMX Health Care
- PHUN Technology
- Exchange
- CTMX Nasdaq
- PHUN Nasdaq
- Market Cap
- CTMX 544.2M
- PHUN 55.9M
- IPO Year
- CTMX 2015
- PHUN N/A
- Fundamental
- Price
- CTMX $3.20
- PHUN $2.69
- Analyst Decision
- CTMX Strong Buy
- PHUN Buy
- Analyst Count
- CTMX 5
- PHUN 2
- Target Price
- CTMX $5.30
- PHUN $7.75
- AVG Volume (30 Days)
- CTMX 4.5M
- PHUN 250.8K
- Earning Date
- CTMX 11-06-2025
- PHUN 11-06-2025
- Dividend Yield
- CTMX N/A
- PHUN N/A
- EPS Growth
- CTMX 263.20
- PHUN N/A
- EPS
- CTMX 0.49
- PHUN N/A
- Revenue
- CTMX $141,100,000.00
- PHUN $2,400,000.00
- Revenue This Year
- CTMX N/A
- PHUN N/A
- Revenue Next Year
- CTMX N/A
- PHUN $72.40
- P/E Ratio
- CTMX $6.54
- PHUN N/A
- Revenue Growth
- CTMX 18.01
- PHUN N/A
- 52 Week Low
- CTMX $0.40
- PHUN $2.22
- 52 Week High
- CTMX $3.51
- PHUN $14.60
- Technical
- Relative Strength Index (RSI)
- CTMX 61.74
- PHUN 43.25
- Support Level
- CTMX $3.21
- PHUN $2.80
- Resistance Level
- CTMX $3.48
- PHUN $3.13
- Average True Range (ATR)
- CTMX 0.20
- PHUN 0.18
- MACD
- CTMX -0.03
- PHUN -0.02
- Stochastic Oscillator
- CTMX 33.71
- PHUN 8.00
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About PHUN Phunware Inc.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services.